Workflow guide · Competitive and thematic coverage

Prepare for conference data season

Separate abstracts, new data, updates, and encore presentations.

Biotech Research AnalystsUpdated 2026-07-26Practical workflow

The situation

When this workflow becomes useful

Several covered and competitor companies plan medical-conference disclosures within a compressed abstract and presentation schedule.

Best fit

Sell-side, buy-side, independent, and corporate analysts responsible for ongoing biotech company or therapeutic-area coverage.

The challenge

Why the obvious approach breaks down

Separate abstracts, new data, updates, and encore presentations. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information.

How to think about the task

The reasoning behind the workflow

Several covered and competitor companies plan medical-conference disclosures within a compressed abstract and presentation schedule. For research analysts, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again.

Separate abstracts, new data, updates, and encore presentations. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later.

Start with the decision this work must support

“Prepare for conference data season” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful.

Build a source-linked change record

The core monitoring set for this workflow includes expected new data, prior-data baseline, presentation schedule, competitive read-through, publication and follow-up deadlines. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot.

Turn monitoring into an owned output

A conference research plan with priority programs, expected changes, comparison points, owners, and post-meeting updates. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The analyst enters the meeting with defined evidence questions and avoids treating every abstract as equally material.

Illustrative example

Illustrative workflow: prepare for conference data season

Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change.

Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event.

Questions to answer before making a decision

  • What has changed in expected new data, and why does it matter?
  • What has changed in prior-data baseline, and why does it matter?
  • What has changed in presentation schedule, and why does it matter?
  • What has changed in competitive read-through, and why does it matter?
  • What has changed in publication and follow-up deadlines, and why does it matter?

The workflow

A repeatable way to do the work

  1. 01

    Define the specific decision or research question behind “prepare for conference data season.”

  2. 02

    Set the monitored scope around expected new data and prior-data baseline.

  3. 03

    Collect source-linked updates for presentation schedule and record what changed from the prior state.

  4. 04

    Review competitive read-through together with publication and follow-up deadlines before drawing a conclusion.

  5. 05

    Produce the required output, assign follow-up ownership, and set the next review point.

Monitoring checklist

Signals to keep visible

Expected new data
Prior-data baseline
Presentation schedule
Competitive read-through
Publication and follow-up deadlines

Common mistakes

  • Starting the monitoring process without a defined decision question
  • Recording the latest state without preserving its source or previous state
  • Ending with collected information but no owner, conclusion, or next review

Output and outcome

What good looks like

Deliverable

A conference research plan with priority programs, expected changes, comparison points, owners, and post-meeting updates.

Practical outcome

The analyst enters the meeting with defined evidence questions and avoids treating every abstract as equally material.

Where BioPharmSignal fits

Reduce the collection work around the decision.

Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.

Frequently asked questions

Who is this workflow for?

It is designed for biotech research analysts and adjacent biotech research users who need a repeatable, source-linked way to complete this task.

What should this workflow produce?

A conference research plan with priority programs, expected changes, comparison points, owners, and post-meeting updates.

What is the practical benefit?

The analyst enters the meeting with defined evidence questions and avoids treating every abstract as equally material.